Back
Day Range
$176.36
$182.16
52-Week Range
$122.00
$208.31
Volume
1,442,477
50D / 200D Avg
$176.25
/
$159.78
Prev Close
$173.18
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 31.6 | 0.4 |
| P/B | 3.2 | 2.9 |
| ROE % | 10.4 | 3.7 |
| Net Margin % | 10.2 | 3.8 |
| Rev Growth 5Y % | 0.5 | 10.0 |
| D/E | 0.0 | 0.2 |
Key Takeaways
Revenue grew 0.52% annually over 5 years — modest growth
ROE of 10.39% — decent returns on equity
Debt/Equity of 0.03 — conservative balance sheet
Generating 490.78M in free cash flow
P/E of 31.62 — premium valuation
Cash machine — converts 119.60% of earnings into free cash flow
Growth
Revenue Growth (5Y)
0.52%
Revenue (1Y)0.90%
Earnings (1Y)-2.61%
FCF Growth (3Y)-10.16%
Quality
Return on Equity
10.39%
ROIC11.10%
Net Margin10.17%
Op. Margin15.27%
Safety
Debt / Equity
0.03
Current Ratio1.36
Interest Coverage0.00
Valuation
P/E Ratio
31.62
P/B Ratio3.20
EV/EBITDA19.49
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 0.90% | Revenue Growth (3Y) | 2.21% |
| Earnings Growth (1Y) | -2.61% | Earnings Growth (3Y) | -3.98% |
| Revenue Growth (5Y) | 0.52% | Earnings Growth (5Y) | -14.61% |
| Profitability | |||
| Revenue (TTM) | 4.03B | Net Income (TTM) | 410.35M |
| ROE | 10.39% | ROA | 6.58% |
| Gross Margin | 68.33% | Operating Margin | 15.27% |
| Net Margin | 10.17% | Free Cash Flow (TTM) | 490.78M |
| ROIC | 11.10% | FCF Growth (3Y) | -10.16% |
| Safety | |||
| Debt / Equity | 0.03 | Current Ratio | 1.36 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 31.62 | P/B Ratio | 3.20 |
| P/S Ratio | 3.22 | PEG Ratio | 51.80 |
| EV/EBITDA | 19.49 | Dividend Yield | 0.00% |
| Market Cap | 12.98B | Enterprise Value | 12.01B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 4.03B | 4.00B | 3.86B | 3.73B | 3.95B |
| Net Income | 410.35M | 421.36M | 445.05M | 361.57M | 772.02M |
| EPS (Diluted) | 5.65 | 5.62 | 5.81 | 4.61 | 9.69 |
| Gross Profit | 2.76B | 2.80B | 2.71B | 2.63B | 2.94B |
| Operating Income | 616.22M | 607.63M | 643.34M | 642.60M | 976.40M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 6.23B | 6.21B | 6.08B | 5.95B | 5.94B |
| Total Liabilities | 2.18B | 2.36B | 2.45B | 2.35B | 2.32B |
| Shareholders' Equity | 4.05B | 3.85B | 3.63B | 3.60B | 3.62B |
| Total Debt | 114.45M | 119.28M | 126.62M | 126.91M | 125.38M |
| Cash & Equivalents | 1.08B | 1.04B | 937.44M | 942.05M | 1.10B |
| Current Assets | 2.62B | 2.49B | 2.45B | 2.42B | 2.49B |
| Current Liabilities | 1.92B | 2.04B | 2.07B | 1.93B | 1.92B |